ALVO SDB
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
Alvotech is a biotechnology company that focuses on the development and manufacture of biosimilar medicines. The company's pipeline consists of biosimilar candidates aimed at treating autoimmune diseases, eye diseases, osteoporosis and cancer. The company offers its products to patients all over the world. Alvotech was founded in 2013 and has its headquarters in Reykjavík.
Lue lisääOsavuosikatsaus Q2'26
Osavuosikatsaus Q3'26
Vuosikatsaus '26
Liikevaihto mrd.
EBIT-% (oik.)
EPS (oik.)
Osinko %
Älä jää mistään paitsi – luo käyttäjätunnus ja ota kaikki hyödyt irti Inderesin palvelusta.